U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 9 of 9 results

Status:
US Approved Rx (2017)
First approved in 1986

Class (Stereo):
CHEMICAL (ACHIRAL)



Tranexamic acid is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin. Tranexamic acid is a competitive inhibitor of plasminogen activation, and at much higher concentrations, a noncompetitive inhibitor of plasmi...
Status:
Other

Class (Stereo):
CHEMICAL (ACHIRAL)

Targets:

Conditions:

cis-Tranexamic acid blocks the plasminogen, and thus possesses antifibrinolytic properties.
Status:
Possibly Marketed Outside US
First approved in 2019

Class (Stereo):
CHEMICAL (ACHIRAL)

Aminomethylbenzoic acid (or p-aminomethylbenzoic acid, or PAMBA) an antifibrinolytic agent. This drug has been used for the treatment of internal hemorrhage during chronic disseminated intravascular coagulation.
Status:
Possibly Marketed Outside US
First approved in 2021

Class:
PROTEIN